Follow-up Study to Assess One Boost Immunization With AFFITOPEŽ PD01A With Regard to
Follow-up Study to Assess One Boost Immunization With AFFITOPEŽ PD01A With Regard to Safety and Clinical Activity (AFF008A)
http://clinicaltrials.gov/ct2/show/N...&sel_rss=mod14 This is a follow-up study to assess safety and clinical activity of continued AFFITOPEŽ PD01A vaccinations in patients with Parkinson's disease. Patients, who have already participated in AFF008 will be involved and will be receive one boost immunization with AFFITOPEŽ PD01A. One study site in Vienna (Austria) will be involved. In addition, up to 8 patients will be offered participation within an untreated control group. |
Quote:
|
It's also invitation only and has no waiting list. "Unless you know somebody"
|
All times are GMT -5. The time now is 12:45 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.